Related Experiment Video
Updated: Nov 24, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Association between lipoprotein (a) level and chronic cardio-renal syndrome in elderly patients]
1Department of Geriatric Cardiology, Hebei General Hospital, Shijiazhuang 050051, China.
Insights
Elevated lipoprotein(a) [Lp(a)] levels are independently associated with chronic cardio-renal syndrome (CRS) in elderly patients, indicating a significant risk factor for this condition.
Area of Science:
- Cardiology
- Nephrology
- Geriatrics
- Clinical Biochemistry
Background:
- Cardio-renal syndrome (CRS) is a complex condition affecting elderly patients with chronic heart failure (CHF).
- Lipoprotein(a) [Lp(a)] is a recognized cardiovascular risk factor, but its specific role in CRS remains under investigation.
Purpose of the Study:
- To investigate the association between serum lipoprotein(a) [Lp(a)] levels and the prevalence of chronic cardio-renal syndrome (CRS) in elderly patients.
- To identify Lp(a) as a potential independent risk factor for CRS in this demographic.
Main Methods:
- Retrospective study of 172 elderly CHF patients (age ≥ 65) categorized into CRS (eGFR < 60 ml·min⁻¹·1.73 m⁻²) and non-CRS (eGFR ≥ 60 ml·min⁻¹·1.73 m⁻²) groups.
- Clinical data, including Lp(a) levels and left ventricular ejection fraction (LVEF), were collected and analyzed.
- Multivariate logistic regression and subgroup analyses were performed to assess the relationship between Lp(a) and CRS, considering comorbidities like coronary heart disease and hypertension.
Main Results:
- Patients in the CRS group exhibited significantly higher Lp(a) levels compared to the CHF group (P<0.05).
- Lp(a) levels showed a negative correlation with both LVEF (r=-0.155, P=0.043) and estimated glomerular filtration rate (eGFR) (r=-0.220, P=0.004) in the overall cohort.
- Multivariate analysis identified age and Lp(a) as independent correlates of CRS (OR=3.719 for Lp(a), P=0.012), with Lp(a) also being an independent factor in subgroups with coronary heart disease and hypertension.
Conclusions:
- Elevated serum Lp(a) levels are independently associated with the presence of chronic cardio-renal syndrome in elderly patients.
- Lp(a) may serve as a valuable biomarker for identifying elderly patients at higher risk of developing CRS, particularly those with underlying coronary heart disease or hypertension.
Abstract:
Objective: To explore the relationship between lipoprotein(a) [Lp(a)] and chronic cardio-renal syndrome (CRS) in elderly patients. Methods: Chronic heart failure (CHF) patients age ≥ 65 years old, who hospitalized in the department of Cardiology of Hebei General Hospital from December 2017 to October 2019, were included in this study. According to the estimate glomerular filtration rate (eGFR) level, patients were divided into CRS group (eGFR<60 ml·min-1·1.73 m-2) and CHF group (eGFR ≥60 ml·min-1·1.73 m-2). The blood index and basic disease information were collected and compared. Left ventricular ejection fraction (LVEF) were measured by echocardiography. The correlation between clinical indicators and cardio-renal function (LVEF and eGFR) was assessed. The multivariate logistic regression analysis was used to evaluate the related risk factors of CRS in elderly patients; subgroup logistic regression analysis was performed according to the basic disease of patients to assess the relationship between Lp(a) and CRS. Results: A total of 172 elderly patients (85 males (49.4%), aged 79 (71, 84) years) were finally enrolled. Among them, 88 cases (51.2%) were in CRS group and 84 cases (48.8%) were in CHF group. Age (80 (74, 84) years old vs. 74 (70, 82) years old) and LP (a) levels (222.0 (112.0, 445.3) mg/L vs. 155.0 (97.0, 348.7) mg/L) were significantly higher in the CRS group than in the CHF group (P<0.05). Lp(a) levels were negatively correlated with LVEF (r=-0.155, P=0.043) and eGFR (r=-0.220, P=0.004) in total cohort. In the subgroup analysis of patients with 2 high-incidence basic diseases (coronary heart disease and hypertension), Lp(a) was negatively correlated with LVEF (r=-0.250, P=0.007) in the coronary heart disease group, and negatively correlated with eGFR (r=-0.233, P=0.013) in the hypertension group. Multivariate logistic regression analysis showed that age (OR = 1.069, 95%CI: 1.017-1.124, P= 0.009) and Lp(a) (OR = 3.719, 95%CI: 1.339-10.326, P = 0.012) were independent correlates of CRS. The results of logistic regression analysis showed that Lp(a) was an independent correlative factor of CRS in the subgroups of coronary heart disease (OR=3.207, 95%CI: 1.129-9.108, P=0.029) and hypertension (OR=3.054, 95%CI: 1.086-8.587, P=0.034). Conclusion: Serum Lp(a) level is independently related with CRS in elderly patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Nephrotic Syndrome I : Introduction
